Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.50
-0.20 (-1.07%)
At close: Jun 26, 2026, 4:00 PM EDT
18.72
+0.22 (1.20%)
After-hours: Jun 26, 2026, 7:43 PM EDT
Caris Life Sciences Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Caris Life Sciences stock have an average target of 27.92, with a low estimate of 21 and a high estimate of 36. The average target predicts an increase of 50.92% from the current stock price of 18.50.
Analyst Consensus: Buy
* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Caris Life Sciences stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 10 | 10 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Jun 1, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $28 | Buy | Maintains | $28 | +51.35% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $21 | Hold | Maintains | $21 | +13.51% | May 12, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $36 | Buy | Reiterates | $36 | +94.59% | May 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $30 | Buy | Maintains | $30 | +62.16% | May 9, 2026 |
Financial Forecast
Revenue This Year
1.00B
from 812.03M
Increased by 23.67%
Revenue Next Year
1.20B
from 1.00B
Increased by 19.91%
EPS This Year
0.13
from -0.41
EPS Next Year
0.37
from 0.13
Increased by 175.28%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | 1.2B | |
| Avg | 1.0B | 1.2B | |
| Low | 973.1M | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 24.4% | 24.1% | |
| Avg | 23.7% | 19.9% | |
| Low | 19.8% | 9.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.33 | 0.52 | |
| Avg | 0.13 | 0.37 | |
| Low | - | 0.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 291.4% | |
| Avg | - | 175.3% | |
| Low | - | 28.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.